Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis

J.S. Smolen, M. Boers, E.C. Abadie, F.C. Breedveld, P Emery, T Bardin, N. Goel, D.J. Ethgen, B.P. Avouac, P. Durez, B. Flamion, A. Laslop, P. Miossec, S. Reiter, J.Y. Reginster

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1732-1736
Issue number10
Publication statusPublished - 2011

Cite this